US Broker Ratings

ICU Medical, Inc. (ICUI) Investor Outlook: 24.8% Potential Upside Amidst Healthcare Innovation

ICU Medical, Inc. (NASDAQ: ICUI), a key player in the medical instruments and supplies industry, offers a compelling prospect for investors seeking exposure to the healthcare sector. Based in San..

CRISPR Therapeutics AG (CRSP)

⚠️ No article content returned.

..

BrightSpring Health Services, Inc. (BTSG) Stock Analysis: A 14.43% Potential Upside Beckons Investors

BrightSpring Health Services, Inc. (BTSG), a prominent player in the Healthcare sector, specifically within Health Information Services, is captivating investor attention with its significant potential upside of 14.43%. Headquartered in..

Inspire Medical Systems, Inc. (INSP) Stock Analysis: Evaluating a 38.65% Potential Upside in the Dynamic Medical Devices Sector

Inspire Medical Systems, Inc. (NASDAQ: INSP) stands out in the medical devices sector with its innovative approach to treating obstructive sleep apnea (OSA). Headquartered in Golden Valley, Minnesota, Inspire Medical..

Integer Holdings Corporation (ITGR) Stock Analysis: Navigating Market Volatility in the Medical Device Sector

Integer Holdings Corporation (NYSE: ITGR) operates at the heart of the healthcare sector, focusing on the design and manufacturing of medical devices. With a market capitalization of $3.01 billion, this..

TransMedics Group, Inc. (TMDX) Stock Analysis: Unlocking a 11% Upside in the Medical Device Sector

TransMedics Group, Inc. (NASDAQ: TMDX) is a compelling player in the healthcare sector, specifically within the medical devices industry. With its innovative approach to organ transplant therapy, the company is..

Regencell Bioscience Holdings (RGC) Stock Analysis: Navigating the Challenges of a $15.44 Billion Market Cap in the TCM Sector

Regencell Bioscience Holdings Limited (NASDAQ: RGC) stands at a fascinating intersection of healthcare innovation and traditional Chinese medicine (TCM), focusing on the development and commercialization of treatments for neurocognitive disorders..

Waystar Holding Corp. (WAY) Stock Analysis: Exploring a Potential 108% Upside with Strong Buy Ratings

Investors are increasingly turning their attention to Waystar Holding Corp. (WAY), a key player in the Health Information Services industry, particularly after recent analyst ratings suggest a significant potential upside...

Krystal Biotech, Inc. (KRYS) Stock Analysis: A Promising Play in Genetic Medicine with a 2.89% Upside Potential

Krystal Biotech, Inc. (NASDAQ: KRYS) has emerged as a compelling player in the healthcare sector, particularly within the biotechnology industry, as it continues to make strides in the development and..

Rhythm Pharmaceuticals, Inc. (RYTM) Stock Analysis: A 44% Upside Potential in the Biotech Space

Rhythm Pharmaceuticals, Inc. (NASDAQ: RYTM) is a key player in the biotechnology sector, focusing on the development of treatments for rare neuroendocrine diseases. As a commercial-stage biopharmaceutical company, Rhythm has..

Roivant Sciences Ltd. (ROIV) Stock Analysis: Assessing the 19.95% Potential Upside Amidst Biotech Innovations

Roivant Sciences Ltd. (NASDAQ: ROIV), a prominent name in the biotechnology sector, is making waves with its ambitious strides in medical technologies and drug development. Founded in 2014 and based..

Grifols, S.A. (GRFS) Stock Analysis: Unveiling a 19.10% Potential Upside in the Healthcare Sector

Investors looking for opportunities in the healthcare sector could find Grifols, S.A. (NASDAQ: GRFS) a compelling consideration. This Spanish pharmaceutical company, specializing in plasma-derived therapies and biological products, is positioned..

Cytokinetics, Incorporated (CYTK) Stock Analysis: A 35.74% Potential Upside Fuels Investor Interest

Cytokinetics, Incorporated (NASDAQ: CYTK), a prominent player in the biotechnology sector, is garnering significant attention from investors, thanks to its robust pipeline of muscle activators and inhibitors designed to treat..

The Ensign Group, Inc. (ENSG) Stock Analysis: Healthcare Leader Eyes 3.31% Upside Amid Robust Growth

The Ensign Group, Inc. (NASDAQ: ENSG) stands as a formidable player in the healthcare sector, specifically within the medical care facilities industry. With a market capitalization of $12.4 billion, the..

RadNet, Inc. (RDNT) Stock Analysis: A 31.94% Potential Upside Amidst Robust Revenue Growth

RadNet, Inc. (NASDAQ: RDNT), a prominent player in the healthcare sector, specifically in diagnostics and research, is capturing investor attention with its significant potential upside and robust revenue growth. With..

Bio-Rad Laboratories, Inc. (BIO) Stock Analysis: Unveiling a 27.85% Potential Upside in the Healthcare Sector

Bio-Rad Laboratories, Inc. (NYSE: BIO), a prominent player in the healthcare sector, specifically within the medical devices industry, holds an intriguing position for investors seeking growth potential. With a market..

Genmab A/S (GMAB) Stock Analysis: Unveiling a 26.3% Potential Upside with Strong Revenue Growth

Genmab A/S (NASDAQ: GMAB), a prominent player in the biotechnology sector, is capturing the attention of investors with its robust product pipeline and impressive revenue growth. Based in Denmark, Genmab..

Neurocrine Biosciences, Inc. (NBIX) Stock Analysis: Exploring a 43.24% Potential Upside for Healthcare Investors

Neurocrine Biosciences, Inc. (NASDAQ: NBIX) is making waves in the healthcare sector with a significant potential upside of 43.24%, drawing considerable interest from investors. With a robust market capitalization of..

Legend Biotech Corporation (LEGN) Stock Analysis: Exploring a 244.69% Potential Upside in Revolutionary CAR-T Therapies

Legend Biotech Corporation (NASDAQ: LEGN), a prominent player in the biotechnology sector, has been making waves with its innovative approach to cell therapy. Headquartered in Somerset, New Jersey, Legend Biotech..

Oscar Health, Inc. (OSCR) Stock Analysis: Navigating Challenges with a 14.75% Potential Upside

Oscar Health, Inc. (NYSE: OSCR) is a prominent player in the healthcare sector, specifically within the healthcare plans industry. With a robust market capitalization of $3.99 billion, Oscar Health has..

Search

Funds

US Broker Ratings

Search

Funds

US Broker Ratings

FTSE 100

Funds